{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:53:52Z","timestamp":1770782032216,"version":"3.50.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,8,15]],"date-time":"2008-08-15T00:00:00Z","timestamp":1218758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00280-008-0815-6","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T07:50:55Z","timestamp":1218700255000},"page":"911-918","source":"Crossref","is-referenced-by-count":22,"title":["The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population"],"prefix":"10.1007","volume":"63","author":[{"given":"Zhao-Hui","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,15]]},"reference":[{"key":"815_CR1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.seminoncol.2004.04.022","volume":"31","author":"JS Macdonald","year":"2004","unstructured":"Macdonald JS (2004) Treatment of localized gastric cancer. Semin Oncol 31:566\u2013573","journal-title":"Semin Oncol"},{"key":"815_CR2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008377101672","volume":"11","author":"E Mari","year":"2000","unstructured":"Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R, Torri V (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell\u2019Apparato Digerente). Ann Oncol 11:837\u2013843","journal-title":"Ann Oncol"},{"key":"815_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1634\/theoncologist.11-2-136","volume":"11","author":"M Hejna","year":"2006","unstructured":"Hejna M, Wohrer S, Schmidinger M, Raderer M (2006) Postoperative chemotherapy for gastric cancer. Oncologist 11:136\u2013145","journal-title":"Oncologist"},{"key":"815_CR4","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1053\/j.seminoncol.2005.06.005","volume":"32","author":"A Carrato","year":"2005","unstructured":"Carrato A, Gallego-Plazas J, Guillen-Ponce C (2005) Adjuvant therapy of resected gastric cancer is necessary. Semin Oncol 32:S105\u2013S108","journal-title":"Semin Oncol"},{"key":"815_CR5","first-page":"2805","volume":"22","author":"Y Ishida","year":"2002","unstructured":"Ishida Y, Kawakami K, Tanaka Y, Kanehira E, Omura K, Watanabe G (2002) Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer. Anticancer Res 22:2805\u20132809","journal-title":"Anticancer Res"},{"key":"815_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bjc.6602891","volume":"94","author":"E Goekkurt","year":"2006","unstructured":"Goekkurt E, Hoehn S, Wolschke C, Wittmer C, Stueber C, Hossfeld DK, Stoehlmacher J (2006) Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)\u2013novel predictors for response and survival in gastric cancer patients. Br J Cancer 94:281\u2013286","journal-title":"Br J Cancer"},{"key":"815_CR7","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1002\/ijc.22235","volume":"119","author":"K Ott","year":"2006","unstructured":"Ott K, Vogelsang H, Marton N, Becker K, Lordick F, Kobl M, Schuhmacher C, Novotny A, Mueller J, Fink U, Ulm K, Siewert JR, Hofler H, Keller G (2006) The thymidylate synthase tandem repeat promoter polymorphism: a predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancer. Int J Cancer 119:2885\u20132894","journal-title":"Int J Cancer"},{"key":"815_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.coph.2006.05.002","volume":"6","author":"DJ Park","year":"2006","unstructured":"Park DJ, Lenz HJ (2006) Determinants of chemosensitivity in gastric cancer. Curr Opin Pharmacol 6:337\u2013344","journal-title":"Curr Opin Pharmacol"},{"key":"815_CR9","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.3748\/wjg.v13.i37.5030","volume":"13","author":"D Hua","year":"2007","unstructured":"Hua D, Huang ZH, Mao Y, Deng JZ (2007) Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer. World J Gastroenterol 13:5030\u20135034","journal-title":"World J Gastroenterol"},{"key":"815_CR10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/sj.bjc.6604317","volume":"98","author":"J Wei","year":"2008","unstructured":"Wei J, Zou Z, Qian X, Ding Y, Xie L, Sanchez JJ, Zhao Y, Feng J, Ling Y, Liu Y, Yu L, Rosell R, Liu B (2008) ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen. Br J Cancer 98:1398\u20131402","journal-title":"Br J Cancer"},{"key":"815_CR11","first-page":"3249","volume":"19","author":"K Kawakami","year":"1999","unstructured":"Kawakami K, Omura K, Kanehira E, Watanabe Y (1999) Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 19:3249\u20133252","journal-title":"Anticancer Res"},{"key":"815_CR12","first-page":"4096","volume":"7","author":"K Kawakami","year":"2001","unstructured":"Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, Omura K, Watanabe G, Danenberg PV (2001) Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res 7:4096\u20134101","journal-title":"Clin Cancer Res"},{"key":"815_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00008571-200405000-00007","volume":"14","author":"MV Mandola","year":"2004","unstructured":"Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, Iqbal S, Lenz HJ, Ladner RD (2004) A 6\u00a0bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 14:319\u2013327","journal-title":"Pharmacogenetics"},{"key":"815_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-6147(00)01675-8","volume":"22","author":"PM Ueland","year":"2001","unstructured":"Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE (2001) Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22:195\u2013201","journal-title":"Trends Pharmacol Sci"},{"key":"815_CR15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/djh015","volume":"96","author":"KJ Sohn","year":"2004","unstructured":"Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI (2004) Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 96:134\u2013144","journal-title":"J Natl Cancer Inst"},{"key":"815_CR16","first-page":"1611","volume":"9","author":"V Cohen","year":"2003","unstructured":"Cohen V, Panet-Raymond V, Sabbaghian N, Morin I, Batist G, Rozen R (2003) Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. Clin Cancer Res 9:1611\u20131615","journal-title":"Clin Cancer Res"},{"key":"815_CR17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2005.06.219","volume":"23","author":"A Jakobsen","year":"2005","unstructured":"Jakobsen A, Nielsen JN, Gyldenkerne N, Lindeberg J (2005) Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity. J Clin Oncol 23:1365\u20131369","journal-title":"J Clin Oncol"},{"key":"815_CR18","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1200\/JCO.2005.04.8322","volume":"24","author":"A Ruzzo","year":"2006","unstructured":"Ruzzo A, Graziano F, Kawakami K, Watanabe G, Santini D, Catalano V, Bisonni R, Canestrari E, Ficarelli R, Menichetti ET, Mari D, Testa E, Silva R, Vincenzi B, Giordani P, Cascinu S, Giustini L, Tonini G, Magnani M (2006) Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J Clin Oncol 24:1883\u20131891","journal-title":"J Clin Oncol"},{"key":"815_CR19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/CAD.0b013e3280b10d23","volume":"18","author":"L Pare","year":"2007","unstructured":"Pare L, Altes A, Ramon y Cajal T, Del Rio E, Alonso C, Sedano L, Barnadas A, Baiget M (2007) Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil\/methotrexate-based therapy. Anticancer Drugs 18:821\u2013825","journal-title":"Anticancer Drugs"},{"key":"815_CR20","doi-asserted-by":"crossref","unstructured":"Huang ZH, Hua D, Li LH, Zhu JD (2008) Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy. J Cancer Res Clin Oncol (in press)","DOI":"10.1007\/s00432-008-0380-8"},{"key":"815_CR21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1054\/bjoc.2001.2007","volume":"85","author":"B Iacopetta","year":"2001","unstructured":"Iacopetta B, Grieu F, Joseph D, Elsaleh H (2001) A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer 85:827\u2013830","journal-title":"Br J Cancer"},{"key":"815_CR22","first-page":"637","volume":"17","author":"E Martinez-Balibrea","year":"2007","unstructured":"Martinez-Balibrea E, Manzano JL, Martinez-Cardus A, Moran T, Cirauqui B, Catot S, Taron M, Abad A (2007) Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan. Oncol Rep 17:637\u2013645","journal-title":"Oncol Rep"},{"key":"815_CR23","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/1078-0432.CCR-04-0169","volume":"10","author":"T Lecomte","year":"2004","unstructured":"Lecomte T, Ferraz JM, Zinzindohoue F, Loriot MA, Tregouet DA, Landi B, Berger A, Cugnenc PH, Jian R, Beaune P, Laurent-Puig P (2004) Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Clin Cancer Res 10:5880\u20135888","journal-title":"Clin Cancer Res"},{"key":"815_CR24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2006.08.1844","volume":"25","author":"A Ruzzo","year":"2007","unstructured":"Ruzzo A, Graziano F, Loupakis F, Rulli E, Canestrari E, Santini D, Catalano V, Ficarelli R, Maltese P, Bisonni R, Masi G, Schiavon G, Giordani P, Giustini L, Falcone A, Tonini G, Silva R, Mattioli R, Floriani I, Magnani M (2007) Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy. J Clin Oncol 25:1247\u20131254","journal-title":"J Clin Oncol"},{"key":"815_CR25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2005.03.5253","volume":"24","author":"E Dotor","year":"2006","unstructured":"Dotor E, Cuatrecases M, Martinez-Iniesta M, Navarro M, Vilardell F, Guino E, Pareja L, Figueras A, Mollevi DG, Serrano T, de Oca J, Peinado MA, Moreno V, Germa JR, Capella G, Villanueva A (2006) Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment. J Clin Oncol 24:1603\u20131611","journal-title":"J Clin Oncol"},{"key":"815_CR26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","volume":"91","author":"J Stoehlmacher","year":"2004","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ (2004) A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 91:344\u2013354","journal-title":"Br J Cancer"},{"key":"815_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10038-005-0339-4","volume":"51","author":"JW Lu","year":"2006","unstructured":"Lu JW, Gao CM, Wu JZ, Cao HX, Tajima K, Feng JF (2006) Polymorphism in the 3\u2032-untranslated region of the thymidylate synthase gene and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy. J Hum Genet 51:155\u2013160","journal-title":"J Hum Genet"},{"key":"815_CR28","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1158\/1078-0432.CCR-04-2428","volume":"11","author":"K Kawakami","year":"2005","unstructured":"Kawakami K, Graziano F, Watanabe G, Ruzzo A, Santini D, Catalano V, Bisonni R, Arduini F, Bearzi I, Cascinu S, Muretto P, Perrone G, Rabitti C, Giustini L, Tonini G, Pizzagalli F, Magnani M (2005) Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy. Clin Cancer Res 11:3778\u20133783","journal-title":"Clin Cancer Res"},{"key":"815_CR29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ijc.20487","volume":"112","author":"E Marcuello","year":"2004","unstructured":"Marcuello E, Altes A, del Rio E, Cesar A, Menoyo A, Baiget M (2004) Single nucleotide polymorphism in the 5\u2032 tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients. Int J Cancer 112:733\u2013737","journal-title":"Int J Cancer"},{"key":"815_CR30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00280-005-0089-1","volume":"57","author":"E Marcuello","year":"2006","unstructured":"Marcuello E, Altes A, Menoyo A, Rio ED, Baiget M (2006) Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy? Cancer Chemother Pharmacol 57:835\u2013840","journal-title":"Cancer Chemother Pharmacol"},{"key":"815_CR31","first-page":"958","volume":"23","author":"JW Lu","year":"2004","unstructured":"Lu JW, Gao CM, Wu JZ, Sun XF, Wang L, Feng JF (2004) Relationship of methylenetetrahydrofolate reductase C677T polymorphism and chemosensitivity to 5-fluorouracil in gastric carcinoma. Ai Zheng 23:958\u2013962","journal-title":"Ai Zheng"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-008-0815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-008-0815-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-008-0815-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:06:54Z","timestamp":1559038014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-008-0815-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,15]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s00280-008-0815-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,15]]}}}